The autophagy factor ATG12~ATG5 conjugate exhibits E3 ligase-like activity which facilitates the lipidation of members of the LC3 family. The crystal structure of the human ATG12~ATG5 conjugate bound to the N-terminal region of ATG16L1, the factor that recruits the conjugate to autophagosomal membranes, reveals an integrated architecture in which ATG12 docks onto ATG5 through conserved residues. ATG12 and ATG5 are oriented such that other conserved residues on each molecule, including the conjugation junction, form a continuous surface patch. Mutagenesis data support the importance of both the interface between ATG12 and ATG5 and the continuous patch for E3 activity. The ATG12~ATG5 conjugate interacts with the E2 enzyme ATG3 with high affinity through another surface location that is exclusive to ATG12, suggesting a different role of the continuous patch in E3 activity. These findings provide a foundation for understanding the mechanism of LC3 lipidation. npg
a r t i c l e s Autophagy is a catabolic process that contributes to nutrient homeo stasis and damage control in eukaryotic cells [1] [2] [3] [4] . During autophagy, cytoplasmic materials, such as proteins, protein aggregates, dam aged organelles and invasive bacteria, are encapsulated in double membrane-bound vesicles called autophagosomes and transported to lysosomes for degradation 2, [5] [6] [7] [8] [9] . Autophagosomes form de novo in the cytoplasm, which is unusual for a vesicular system, but current descriptions of this process are limited to the morphological level. At the molecular level, many protein factors are known to participate in autophagosome formation 9 . One category of these proteins includes the ubiquitinlike proteins of the LC3 family consisting of seven mem bers in mammals (Atg8 in yeast) and the conserved ATG12 (Atg12 in yeast) 10, 11 . Upon induction of autophagy, LC3 becomes conjugated to phosphatidylethanolamine at autophagosomeforming sites, where this conjugate has crucial roles in the control of membrane dynamics and in substrate recruitment [12] [13] [14] [15] . In contrast, ATG12 is constitutively conjugated to ATG5 (ref. 16 ), a structural protein consisting of two ubiquitinlike fold domains (UFDs) and an αhelical bundle region (HBR) on which Lys130, the lysine used for conjugation, is located 17 . The conjugation between ATG12 and ATG5 is essential for LC3 lipidation and therefore for autophagosome formation 13, 16 .
LC3 and ATG12 are conjugated to their respective targets by enzy matic cascades that are analogous to ubiquitination and involve the same E1 activation enzyme, ATG7, but different E2 conjugation enzymes, ATG3 and ATG10 for LC3 and ATG12, respectively 10, 18 . Although these cascades lack canonical E3 ligases such as RING domain-containing proteins, a recent biochemical study showed that the yeast Atg12~Atg5 conjugate facilitates Atg8 transfer from Atg3 to phosphatidylethanolamine in vitro 19 . That report 19 , together with the requirement of ATG12~ATG5 for LC3 lipidation in cells, has led to the recognition of ATG12~ATG5 as the E3 factor for LC3 lipida tion. However, much less is understood about the physical role of the covalent linkage between ATG12 and ATG5, and about determinants required for E3 activity.
ATG3 has been reported to interact with ATG12 (refs. [20] [21] [22] . ATG5 binds to ATG16L1 (Atg16 in yeast), the factor that recruits ATG12~ATG5 to sites of autophagosome formation 13, 14, [22] [23] [24] [25] . Because these interactions can occur independently of the conjuga tion between ATG12 and ATG5, the conjugation provides a simple means of recruiting ATG3 to autophagosomal membranes. This idea is supported by a recent report showing that forced localization of an artificial ATG16L1 construct at the plasma membrane resulted in LC3 lipidation at the plasma membrane 22 . However, given that ATG12 is conjugated to the specific lysine of ATG5, ATG3 recruit ment is unlikely to be the sole purpose of conjugation, unless the specific site is required only for formation of, but not for the function of, ATG12~ATG5. Canonical ubiquitinlike proteins modulate the function of target proteins often by conjugation to specific lysine sites. In several cases, structural evidence has suggested that conjugations of ubiquitinlike proteins also cause conformational changes in the target proteins 26, 27 or that the conjugate provides a new surface for the recruitment of other proteins to specific sites of the target protein 28 . In the case of ATG12~ATG5, it remains to be established whether similar mechanisms operate in addition to ATG3 recruitment.
Here we set out to identify the role of the conjugation between ATG12 and ATG5 in LC3 lipidation. We demonstrate that the native conjugation moeity is crucial for E3 activity using artifical covalent linkages. The crystal structure of human ATG12~ATG5 in complex with the Nterminal region of ATG16L1 (referred to as ATG16N) shows that the conjugate forms an integrated architecture through a r t i c l e s covalent and noncovalent contacts. Structural and mutational ana lyses suggest that both ATG12 and ATG5 are directly involved in E3 activity through residues that are assembled into a continuous surface patch upon conjugation. ATG12 also has another surface patch that is responsible for ATG3 binding. These findings establish the structural role of the covalent linkage in building an architecture required for E3 activity and provide insights into how the E2-E3 interaction occurs.
RESULTS

Native conjugation moiety is critical for E3 activity
To examine the importance of the specific conjugation site of ATG12~ATG5 for E3 activity, we tested the activity of a conjugate mimic generated by genetic tethering of ATG12 and ATG5. It has previously been reported that in Atg5 knockout (Atg5 −/− ) mouse embryonic fibroblasts (MEFs) LC3~phosphatidylethanolamine (also referred to as LC3II in cellular contexts) is not detected 13 . This defect can be restored by expression of wildtype ATG5 but not by expres sion of the conjugationincompetent mutant ATG5 K130R , indicating that ATG12~ATG5 is necessary for LC3II formation 13 . We obtained the same results with stable expression of 3×FlagATG5 using a retro virus system ( Fig. 1a) . We then expressed 3×FlagATG12ATG5 K130R fusion construct, in which the C terminus of ATG12 is fused to the N terminus of ATG5 K130R through a 2×GlyGlySer linker (the K130R mutation prevents conjugation to endogenous ATG12), and assayed LC3II formation. Despite expression of the expected fusion protein in cells, we did not detect LC3II ( Fig. 1a) , even when we induced autophagy by starvation in the presence of chloroquine, a compound that prevents lysosomal degradation of LC3II and therefore allows more sensitive detection of LC3II 29 . We also tested the same fusion protein in an in vitro LC3 lipidation assay and confirmed that it was not active (Fig. 1b) . These data indicate that the attachment of ATG12 to the N terminus of ATG5 does not generate a functional E3.
We next generated another conjugate mimic by chemically cross linking ATG12 and ATG5 molecules at the native conjugation site and examined its E3 activity. To this end, we constructed ATG12 and ATG5 mutants whose residues used for native conjugation were replaced by cysteine (ATG12 G140C and ATG5 K130C ) and native cysteine residues were changed to noncysteine amino acids, and crosslinked these mutant proteins with bismaleimidoethane (BMOE). As a con trol, we made a mutant conjugate containing the same substitutions for the native cysteine residues. Whereas this cysteineless mutant exhibited an E3 activity in vitro ( Fig. 1b) , albeit slightly lower than that of the wild type, the BMOE-crosslinked conjugate mimic was not active (Fig. 1b) , indicating that BMOE crosslinking caused a too large structural deviation from the functional form. These data sup port the importance of the native conjugation moiety and rationalize the need for structural investigation of ATG12~ATG5.
Structure determination of the ATG12~ATG5-ATG16N complex
To gain structural insights into the role of the covalent linkage, we crystallized human ATG12~ATG5 in complex with a 33residue ATG16N construct. Crystals appeared under two different solution conditions and exhibited space groups, P2 1 2 1 2 1 and C2. We solved the native data sets of these crystals by molecular replacement using a model derived from a multiwavelength anomalous diffraction data set collected on a selenomethionineincorporated complex (Online Methods). We refined the structures to resolutions of 2.7 Å and 2.9 Å for the P2 1 2 1 2 1 and C2 data sets, respectively ( Table 1 ). The P2 1 2 1 2 1 and C2 crystals contained two complexes and one complex, respec tively, in the asymmetric unit. Despite the different crystal packing, the structures are overall very similar, as revealed by the low 1.0 Å ± 0.1 Å root mean square (r.m.s.) deviation of all the Cα atoms among the three complex molecules ( Supplementary Fig. 1a ).
Architecture of the ATG12~ATG5-ATG16N complex
In the crystals, ATG12~ATG5-ATG16N formed a compact structure ( Fig. 2a ). As previously observed in the structure of Saccharomyces cerevisiae Atg5-Atg16N 17,30 , ATG16N is bound to a surface of ATG5 consisting of two UFDs (referred to as UFD1 and UFD2, which cor responds to UblA and UblB, respectively, in the previous report 17 ) in an αhelical conformation with a slight kink in the middle. ATG12 is located on ATG5 at the side opposite ATG16N, and there are no contacts between ATG12 and ATG16N. The electron density for the Cterminal residue Gly140 of ATG12 and that for Lys130 of ATG5 are clearly connected, validating our structure as the conjugated form ( Supplementary Fig. 1b ). There are no major conformational changes in ATG12 and ATG5 upon conjugation ( Fig. 2b and Supplementary  Fig. 1c ). Although Arabidopsis thaliana ATG12b in the previous crystal structure formed a domainswapped dimer 30 , ATG12 in our structure is monomeric. At a local level, there is a small change in ATG12 upon conjugation. In unconjugated A. thaliana ATG12b, the penultimate tryptophan residue in the Cterminal tail makes contacts with the other monomer in the domainswapped dimer but not with its own UFD 30 . In our structure, the Cterminal tail of ATG12 folds back onto its own UFD through rearranged side chain-side chain interactions that include contacts between the penultimate tryptophan Trp139 and npg a r t i c l e s Tyr103 of its own UFD ( Fig. 2b) . Such conformation of the Cterminal tail of ATG12 has not been observed among structures of ubiquitin like proteins; the C terminus of canonical ubiquitinlike proteins lacks such an aromatic residue and is considered to be flexible 31 .
The noncovalent contacts between ATG12 and ATG5 bury a total of 1,300 Å 2 of solventaccessible surface area (Fig. 2c) . The aliphatic atoms of the side chain of Lys130 are buried in this interface, indicat ing that Lys130 not only provides its εamino group for isopeptide bonding to ATG12 but also has a structural role as part of the inter face. A patch on ATG12 comprising the turnloopturn-alpha helix 2 (α2) segment (Asn105-Phe123) is associated with the interaction surface on ATG5 that is formed by residues from several regions in its primary structure, including UFD1 (Gly14-Lys105), the loop con necting UFD1 and HBR (S106-S117), α4 of HBR (Lys118-His137) and the loop of UFD2 (Phe198-Leu202). This turnloopturnα2 segment is the region that was exchanged between the two mole cules in the A. thaliana ATG12b dimer ( Fig. 2b and Supplementary  Fig. 1d ), indicating that ATG12 may be stabilized upon conjugation. This idea is supported by our observation that unconjugated ATG12 formed oligomers slowly during purification and storage in solution ( Supplementary Fig. 2 ). Phe108 in the turnloopturnα2 segment npg a r t i c l e s of ATG12, whose corresponding residue in yeast Atg12 has previ ously been suggested to be important for autophagy 32 , is located in the center of the interface patch of ATG12 and makes contacts with Glu131 in α4 of ATG5. There is an intermolecular hydrogen bond between the side chains of this Glu131 and Gln114 in α4 of ATG12 as well as a salt bridge between the side chains of Asp113 of ATG12 and His80 in UFD1 of ATG5, which are located at a distal site from the conjugation site ( Fig. 2c) . Evaluation of the properties of this interface using PDBePISA 33 revealed that the interface is hydro phobic, favorable for association, and unlikely to be a specific inter action site, as indicated by a ∆ i G (change in the total solvation energy upon complexation) of −6.8 kcal mol −1 , a ∆ i G P value (P value of the observed solvation freeenergy gain) of 0.25 and a complex forma tion significance score of 0, respectively. Consistent with this result, we did not observe an interaction between unconjugated ATG12 and ATG5 molecules. However, the interface between ATG12 and ATG5 is unlikely to be a crystallographic artifact because essentially the same structure has been observed in two different space groups; the only appreciable difference between the two crystal structures is at the loop between β1 and β2 in UFD1 of ATG5, which is involved in crystal packing in the C2 but not in the P2 1 2 1 2 1 crystal and is far away from the ATG12-ATG5 interface (Supplementary Fig. 1a ). Based on these analyses and considerations, we propose that the architecture of ATG12~ATG5 is based on the stabilization of weak and less specific but favorable hydrophobic interfaces by the covalent linkage and the fixed conformation of the Cterminal tail of ATG12.
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Gln140 Lys138 Leu135 Glu131 that are isolated from the ATG12~ATG5 structure are shown with colors according to the conservation scores obtained from the ConSurf server 44 . Analysis was performed using 50 and 45 sequences of ATG12 and ATG5, respectively ( Supplementary Fig. 5 ). On the surfaces of the isolated ATG12 and ATG5, the interfaces in ATG12~ATG5 are indicated by black borderlines. Highly conserved residues as well as less conserved residues that were tested in mutagenesis experiments are indicated. npg a r t i c l e s
Perturbation of the ATG12-ATG5 interface affects E3 activity
Having revealed the architecture of ATG12~ATG5, we sought to establish its functional importance. Conservation mapping on the surface of each molecule revealed that the ATG12-ATG5 interface contains highly conserved residues, including Phe108 and Asp113 of ATG12, and His80, Leu113, Ser127, Glu131, Arg188 and Gln200 of ATG5 ( Fig. 3) ; this high level of conservation at the interface suggests that there is evolutionary pressure on the ATG12~ATG5 architec ture. To confirm the importance of the interface, we mutated these conserved residues and some additional less conserved peripheral residues and tested E3 activity of the mutants in vitro ( Fig. 4 and  Supplementary Fig. 3) . We included amino acids that are bulkier or have opposite chemical properties compared to the native ones because we predicted that such mutations would interfere with the packing at the interface and thus sterically disrupt the architecture more than alanine would. The results agree well with this prediction: the mutations D113V and C122W in ATG12, and H80L, S127L and A134E in ATG5 severely impaired E3 activity, whereas the effects of the mutations to alanine such as H80A and L113A in ATG5 were moderate, and E131A in ATG5 had no effect. In addition to those mutations, we attempted to test F108A and F108D in ATG12, and E131F in ATG5 but could not do so because these mutations impaired the production of the conjugate in Escherichia coli.
We extended the mutagenesis study to the cellular context to con firm our in vitro results. To test ATG5 mutations in cells, we expressed 3×FlagATG5 mutants in Atg5 −/− MEFs. Mutations at the interface, such as H80A, H80L, S127L, A134E, L135R and Q200W decreased LC3II formation, and some combinations of these single mutations had more severe effects (Fig. 5a) . The decreased amounts of some of ATG12~3×FlagATG5 mutants, such as of H80L and of a few double mutants, are unlikely to affect the interpretation because it has pre viously been demonstrated that amounts of ATG12~ATG5 as low as the detection limit of western blotting are sufficient for LC3II forma tion 34 . The mutations E131A and E131G showed little effect in MEFs. Overall, these data are consistent with the in vitro results described above. Single mutations L113D and E131F, and double mutation H80A L135R abolished the formation of ATG12~3×FlagATG5. We presume that these mutations destabilize the interface in a way that is incom patible with the formation of ATG12~ATG5 or the protein folds.
To test ATG12 mutations in cells, we used wildtype MEFs. When we stably expressed 3×FlagATG12 in wildtype MEFs, we detected 3×FlagATG12~ATG5 and additional 3×FlagATG12-containing bands as well as LC3II-containing bands (Fig. 5b) . This observa tion is consistent with a previous report in which stable expressions of ATG12 in mammalian cells using a retrovirus system similarly generated multiple ATG12containing species but did not affect autophagy 35 . However, we found that the expression of 3×FlagATG12 resulted in ~75% reduction in the amount of LC3II compared to the controls (Fig. 5b) . This reduced amount of LC3II was likely due to the presence of unconjugated 3×FlagATG12 in the cells because expres sion of a conjugationincompetent form, 3×FlagATG12 ∆G140 also showed a reduction simlar to that for the wild type. This interpretation K130R  H80D  H80A  H80L  L113D  S127L  E131A  E131G  E131F  A134E  L135R  Q200W H80A S127L H80A L135R H80A Q200W S127L A134E S127L L135R S127L Q200W  Empty vector  Wild type  D50A  K138A  K138I  K138D  Q140A  Q146A  D149V  H150S  I168D  K171D  K138A N143A  K138A Q146A  K138A D149V  K138A H150S  N143A Q146A  D149V H150S  N143A  M145D  L113A  3×Flag- npg a r t i c l e s is consistent with a previous report that tran sient overexpression of ATG12 in mammalian cells had abolished LC3II formation 22 . While performing this experiment, we noticed that expression of ATG12 caused a downregula tion of endogenous ATG12~ATG5 to a level undetectable in western blots (Fig. 5b) , an effect not discussed in literature previously. These observations suggested that despite the smaller dynamic range described above, the effect of a mutation in ATG12 on LC3II formation could be examined in wildtype MEFs, as long as the expressed 3×Flag ATG12 mutant conjugates with the endo genous ATG5 efficiently enough to knock down the native ATG12~ATG5 as observed with wildtype ATG12 expression. Mutation of most of residues at the interface, such as Phe108, Asp113 and Phe123 in ATG12, did not knock down endogenous ATG12~ATG5 (Fig. 5b) , presumably owing to inefficient conjugation to ATG5; as a result, we could not obtain information on the effects of these mutations on LC3II production. However, the C122W mutant efficiently conjugated to ATG5 and abolished the endogenous ATG12~ATG5. LC3II forma tion was severely inhibited by C122W, consistent with the in vitro data described above. Unconjugated mutants F108A, F108D, F108R and F123D were not detectable ( Fig. 5b) , indicating that these muta tions destabilized the protein. In contrast, the F108I mutant was detectable and conjugated to ATG5. Thus, the hydrophobic nature of Phe108 seems to be necessary for protein stability and conjuga tion to ATG5. But the conjugation was not efficient enough to knock down the endogenous ATG12~ATG5. These observations contrast to a previous report in which the mutation of Phe154 in Atg12, the residue corresponding to Phe108 in ATG12, to alanine or aspartic acid did not affect Atg5 conjugation but impaired Atg8 lipidation in yeast 32 . Although such previous data support our structure, the loss of function resulting from the Phe154 mutations could also have been a consequence of the aggregation of the mutant conjugates as shown in the same report 32 . Indeed, we found that recombinant ATG12 F108D protein aggregated to a much greater degree than the wild type did (Supplementary Fig. 2) . Based on these findings, together with our structure, in which the Phe108 phenyl ring is sandwiched between the hydrophobic core of ATG12 and the interaction surface of ATG5 (Fig. 2c) , we propose that Phe108 is important for the stability of both ATG12 and ATG12~ATG5.
Identification of functional patches on ATG12~ATG5
We next sought to identify potential functional sites on the surface of ATG12~ATG5. Conservation mapping revealed a continuous patch across ATG12 and ATG5 (Fig. 3) . This patch contains the conjuga tion site and the Cterminal residues of ATG12, including Ala138, Trp139 and Gly140. Other residues such as Val62, Gly63, Leu92, Gln106 and Ser107, which are located on various segments of ATG12, and residues such as Lys138, Asn143, Met145, Gln146, His150 and Ile168 in the HBR of ATG5 also participate in this patch. In vitro, ATG5 single mutations including N143A, Q146A, M145D, K138A, K138D, H150S, D149V and I168D and the K138A Q146A double mutation impaired E3 activity severely, whereas Q140A and K171D affected E3 activity only slightly (Fig. 4b,d) . In MEFs, the mutations K138I, K138D, M145D and I168D severely impaired LC3II forma tion, whereas other single mutations affected LC3II formation less (Fig. 5a) . Double mutants based on these less effective mutations severely affected the activity. The in vitro data for ATG12 showed that LC3 lipidation was appreciably reduced by the mutations S107W or Q106A and was abolished by V62R, G63D, A138R, W139F or W139Y (Fig. 4c,d) . In MEFs, only the G63D and Q106A mutants efficiently conjugated with ATG5 and knocked down endogenous ATG12~ATG5 (Fig. 5b) . Consistent with the in vitro data, G63D impaired LC3II formation in MEFs, whereas Q106A did not. Taken together, these data support the importance of the residues in this patch in the E3 activity of this complex (Fig. 5c) .
In addition to the continuous patch, two highly conserved residues of ATG12, Lys54 and Lys72, are located at the side opposite of the ATG12-ATG5 interface (Fig. 3) . Mutation of these residues, as well as of Trp73, located adjacent to these two residues on the surface, abolished E3 activity both in vitro and in MEFs (Figs. 4c,d and 5b,c) ; therefore, these residues make up another functional patch.
ATG12 is responsible for high-affinity binding to ATG3
Understanding how ATG12~ATG5 interacts with ATG3 is essen tial for a mechanistic description of the E3 activity of the conjugate. npg a r t i c l e s Previous data suggest that both ATG12~ATG5 and the unconjugated ATG12 can bind to . However, how these interac tions are related to the E3 activity of ATG12~ATG5 and how ATG5 is involved in this interaction are unclear. To probe the role of ATG5 in the interaction between ATG12~ATG5 and ATG3, we examined the binding abilities of conjugated and unconjugated proteins using isothermal titration calorimetry (ITC). ATG12~ATG5-ATG16N binds tightly to ATG3 with a K d of 51 nM, whereas unconjugated ATG12 binds to ATG3 with a slightly higher K d of 117 nM (Fig. 6a,b) . However, under our experimental conditions, unconjugated ATG5-ATG16N did not show detectable binding to ATG3 (Fig. 6c) . These results establish that the direct contribution of ATG5 to ATG3 bind ing is very small, if such a contribution exists at all. To identify the highaffinity interaction site, we assayed the binding of ATG3 to ATG12~ATG5-ATG16N complexes containing mutations in ATG12. The results show that mutations in the surface patch exclusively on ATG12 affected the binding markedly; the K54D and K72D mutations resulted in greater than 100fold increases in K d values, and the W73A mutant showed no detectable binding ( Fig. 6d-f) . In contrast, ATG12 mutations in the interface to ATG5 (D113V, C122W and A134E) or in the continuous patch (V62R, G63D, S107W, A138R and W139Y) resulted in only minor (less than 2.5fold) differences in K d values (Supplementary Fig. 4) . We also examined some of the ATG5 muta tions that had severely impaired the E3 activity both in vitro and in MEFs (H80L, K138D, M145D, S127L A134E and K138A Q146A) and confirmed that these ATG5 mutations did not affect the binding (Supplementary Fig. 4) .
We verified the effects of the mutations in ATG12 on ATG3 inter action in cells using immunoprecipitation. We immunoprecipitated ATG12 mutant proteins in lysates of the MEFs described above using antiFlag antibody. For this assay, we choose the mutants with mutated sites located on the conjugate surface and that exhibited impaired LC3II formation in cells. Both 3×FlagATG12~ATG5 and 3×Flag ATG12 were detected in the immunoprecipitates (Fig. 7) . Endogenous ATG3 precipitated with wildtype ATG12 but not with the control, demonstrating the interaction between these proteins. The immuno precipitates containing the mutant K54D, K72D or W73A, had markedly less ATG3, whereas a similar amount of ATG3 as for wild type was observed for G63D. The quantification of these immuno complexes indicates that ATG3 interaction was severely weakened by the former three mutations but not much by G63D. These data agree well with the in vitro binding data described above. Thus, we conclude that the ATG12exclusive patch including Lys54, Lys72 and Trp73 is the highaffinity binding site for ATG3, and the patch across ATG12 and ATG5 has a different role in the E3 function.
DISCUSSION
Our structural and mutational analyses of ATG12~ATG5-ATG16N revealed that the conjugation generates a patch across ATG12 and ATG5 required for E3 activity. This finding explains why the ATG12 ATG5 fusion construct was not functional; the ATG12 in the fusion that was attached to the N terminus of ATG5 was too far away from its original position in ATG12~ATG5 to form such a functional patch even with a flexible 2×GlyGlySer linker inserted between ATG12 and ATG5. The BMOE-crosslinked conjugate mimic was inactive perhaps because it could not form the native ATG12~ATG5 architecture owing to the increased number of the chemical bonds in the covalent linkage (eight bonds more than the native isopep tide bond). Alternatively, the extra atoms of BMOE may have caused steric hindrance for a binding partner during the E3 function, as the native conjugation site is located in the continuous patch. Our muta tional analyses also suggested that the interface between ATG12 and ATG5 is important for E3 activity. Although mutations in the inter face that exhibited negative effects are likely to have destabilized the ATG12~ATG5 architecture and thus disrupted the continuous patch, we do not know the precise mechanisms underlying the effects by each mutation. Investigations on these mutants as well as the BMOE conjugate would provide additional insights into the mechanism of the E3 activity of ATG12~ATG5.
We identified a surface location on ATG12 at the side opposite from the interface to ATG5 as the hotspot for ATG3 interaction and demon strated that the residues in the hotspot are important for E3 activity. These data, however, challenge a previous report in which Phe108 of ATG12 was shown to be necessary for ATG3 interaction 22 . This previous conclusion was drawn from the result of an immunoprecipita tion experiment using HEK293A cells overexpressing Phe108 mutants of ATG12. As described above, in our structure Phe108 is located at the interface with ATG5. In principle, it is possible that the mutations of Phe108 allosterically affect ATG3 binding, which occurs at the side opposite Phe108. However, given the aggregationprone nature of the Phe108 mutants, we suggest that the previous observation might have resulted from aggregation or destabilization of the expressed mutant proteins in cells. Ultimately, these contradictory data should be clarified by careful characterizations of the Phe108 mutants.
The next question regarding the E3 function of ATG12~ATG5 is exactly how this conjugate interacts with ATG3 or LC3loaded ATG3 and facilitates the transfer of LC3 to phosphatidyleth anolamine. Unlike E3 ubiquitinligases, ATG12~ATG5 does not appear to contribute specificity in substrate recognition; ATG3 alone can conjugate LC3 to phosphatidylethanolamine in vitro, albeit at much slower rates than in the presence of ATG12~ATG5 (refs. 19,36-38) . Thus, ATG12~ATG5 may function as an E2 stimulating machine analogously to RING domains in ubiquitin ligases. Although ATG12 alone binds tightly to ATG3, ATG12 alone is not sufficient for E3 activity, suggesting that the highaffinity binding site for ATG3 does not stimulate ATG3. Rather, we suggest the possibility that the patch across ATG12 and ATG5 serves this purpose. Our data showing that the affinity of ATG12~ATG5 for ATG3 is only slightly higher than that of ATG12 alone (Fig. 6) indicate that the continuous patch does not contribute much to the affinity for ATG3. However, such low affinity of the patch may be consistent with the typically observed low affinities (K d values of micromolar to millimolar) Figure 7 Point mutations in the binding patch on ATG12 impair ATG3 interaction in MEFs. Western blot of an anti-Flag immunoprecipitation (IP) assay carried out with lysates of MEFs expressing ATG12 constructs. IB, immunoblot. The shown ratios of the amount of ATG3 to the sum of 3×Flag-ATG12-ATG5 and 3×Flag-ATG12 in the immunoprecipitates were normalized against the wild type (WT) and are shown. npg a r t i c l e s between RING domains and E2 enzymes for ubiquitination 39 . Alternatively, the continuous patch may function in stabilizing a conformation of LC3charged ATG3 in an optimal orientation to enhance conjugation, as previously proposed for SUMO and ubiquitin systems [40] [41] [42] [43] . Answers to these questions will be provided by future structural and biochemical studies on larger complexes.
METhODS
Methods and any associated references are available in the online version of the paper.
Accession codes. The structures of human ATG12~ATG5-ATG16N have been deposited to the Protein Data Bank under the accession codes 4GDK and 4GDL.
